Matritech buys company to gain German base
This article was originally published in Clinica
Executive Summary
Matritech, a US cancer screening and diagnostics company developing nuclear matrix protein tests, is to buy its German distributor. The purchase gives the company a European base and will immediately contribute to the it's sales.